Navigation Links
Amylin Sends Letter to Shareholders
Date:5/1/2009

n requests, such as the exenatide once weekly NDA mentioned in this letter, may not be submitted timely or receive FDA approval; risks that our expense reductions will not be as large as we expect; risks that the restructured operations for exenatide will not produce the results we expect; and other risks inherent in the drug development and commercialization process. Commercial and government reimbursement and pricing decisions and the pace of market acceptance may also affect the potential for BYETTA, SYMLIN or exenatide once weekly. These and additional risks and uncertainties are described more fully in the Company's most recently filed Form 10-K. Amylin disclaims any obligation to update these forward-looking statements.

Additional Information and Where To Find It

This press release may be deemed to be solicitation material in respect of the matters to be considered at the 2009 Annual Meeting of Stockholders. Amylin has filed the definitive proxy statement with the Securities and Exchange Commission ("SEC") on April 20, 2009. INVESTORS AND SECURITYHOLDERS ARE URGED TO READ THE PROXY STATEMENT, THE BLUE PROXY CARD AND ANY OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Investors and securityholders may obtain the proxy statement and other relevant documents free of charge at the SEC's Web site, www.sec.gov or from Amylin Investor Relations at 9360 Towne Centre Drive, San Diego, California 92121.

Participants in Solicitation

Amylin and its directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the matters to be considered at the 2009 Annual Meeting of Stockholders. Information regarding the interest
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
2. Amylin Pharmaceuticals to Webcast Third Quarter Results
3. Amylin Pharmaceuticals to Webcast Conference Call
4. Amylin Pharmaceuticals to Present at Research & Development Day
5. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
6. Amylin Pharmaceuticals Reports 2007 Financial Results
7. Amylin Pharmaceuticals Reports First Quarter Financial Results
8. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
9. Lilly and Amylin Set Date and Time for Conference Call
10. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
11. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Silver Spring, Md. (PRWEB) August 27, 2014 ... Physicians (CHEST) recently released guidelines for the management ... adults, Pharmacological Therapy for Pulmonary Arterial Hypertension in ... guidelines are free to view for clinicians, and ... for PAH. , The Pulmonary Hypertension Association ...
(Date:8/27/2014)... Dennis Thompson HealthDay ... Someone who has been mugged in a dark alley will ... with a fear of being attacked. But neuroscientists working ... how memories are linked with positive and negative emotions. And ... emotions attached to a memory. In essence, they made ...
(Date:8/27/2014)... Warren, MI (PRWEB) August 27, 2014 Michigan ... to help the children of a local elementary school by ... year. Siersma Elementary School has year-round attendance, and Michigan Head ... equipped to meet the new school year. , "There are ... think this is a great way to give back to ...
(Date:8/27/2014)... August 27, 2014 The federal judge ... ) has extended the deadline for plaintiffs to enroll ... 2014 Order issued by U.S. District Judge David Katz ... enroll in the DePuy ASR Settlement Program must do ... Inc. ASR Hip Implant Products Liability Litigation – MDL ...
(Date:8/27/2014)... (HealthDay News) -- Pouring half a glass of wine at a ... new study. Researchers asked 74 college students and staff to ... that had varying amounts of wine in them. The participants were ... had a "rule of thumb" about how much to pour -- ... from the top -- poured less wine than those without set ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:'Half a Glass' Rule May Curb Overdrinking 2
... flight surgeons supporting Wyle and its NASA Bioastronautics Contract have ... NASA announced last week that Dr. Kjell Lindgren and Dr. ... Texas Medical Branch (UTMB) in the Department of Preventive ... from a pool of 3,565 applicants. UTMB is one of ...
... N.J., July 1 Zufall Health Center, a federally ... launched the nation,s first eco-friendly mobile medical unit. , ... needed, affordable health care to low-income, mostly uninsured residents ... officials commemorated the launch at a ribbon cutting ceremony ...
... a higher risk of hospitalization or death due to cirrhosis ... with a lower risk. These findings are in the July ... Wiley & Sons on behalf of the American Association for ... available online at Wiley Interscience ( www.interscience.wiley.com ). ...
... mother of an autistic child joined Consumer Watchdog and ... California Department of Managed Health Care ("DMHC"), the Schwarzenegger ... insurers. The suit alleges that the DMHC has wrongfully ... treatments, resulting in the denial of critically needed, medically ...
... , TeamHealth Demonstrates Ongoing Commitment to Patient Care through ... July 1 TeamHealth announced today that it has ... safety. On July 1, its patient safety organization -- ... by the Agency for Healthcare Research and Quality (AHRQ), ...
... , To Expand Access to Its Research, HealthTech Joins With Public ... CalRHIO Board of Directors has appointed Molly Joel Coye, MD, MPH, ... California statewide information exchange founded in 2005. Dr. Coye was ... of the Board of Directors since 2007. , , "Molly ...
Cached Medicine News:Health News:Two Flight Surgeons Supporting Wyle's Bioastronautics Contract Selected for New Astronaut Class 2Health News:Two Flight Surgeons Supporting Wyle's Bioastronautics Contract Selected for New Astronaut Class 3Health News:Nation's First Eco-Friendly Mobile Health Van Launched by New Jersey Non-Profit Health Center 2Health News:Nation's First Eco-Friendly Mobile Health Van Launched by New Jersey Non-Profit Health Center 3Health News:Study examines dietary influences of liver disease 2Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 2Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 3Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 4Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 5Health News:TeamHealth Recognized by National Quality Agency 2Health News:TeamHealth Recognized by National Quality Agency 3Health News:Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO 2Health News:Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO 3
(Date:8/27/2014)... DANVERS, Mass. , Aug. 27, 2014 North ... with a prestigious R&D 100 Award for the new OSRAM ... laser and LED-based white light module for microscopy, endoscopy and ... Xenon lamps with significantly higher efficacy and lamp life. ... as one of the most innovative new technologies of ...
(Date:8/27/2014)... Aug. 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... of pharmaceutical development, clinical trial manufacturing, and advanced analytical ... that it will participate at the upcoming Rodman & ... be held in New York . ... on September 9, 2014 at the New York Palace ...
(Date:8/27/2014)... 27, 2014 /CNW/ - Covalon Technologies Ltd. (the "Company" or ... following financial results for its third quarter of fiscal 2014: ... , Revenue of $1,291,378, a 13% decrease over ... loss for the quarter of $240,156 compared to net income ... For the nine months ended June 30, ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... Medicaid and the State of Alabama are partnering with ... infrastructure for a statewide health information exchange (HIE) that ... (Logo: http://photos.prnewswire.com/prnh/20090507/NY12658LOGO) The partnership is ... diverse group of stakeholders into functional, user-friendly design for ...
... /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) ("Lotus" ... medicine and drugs in the People,s Republic of China ("PRC"), ... ended September 30, 2011. Summary financial data is provided below: ... Financial Highlights Revenues for the ...
Cached Medicine Technology:Alabama Selects Thomson Reuters HIE Advantage™ for Statewide Health Information Exchange 2Alabama Selects Thomson Reuters HIE Advantage™ for Statewide Health Information Exchange 3Lotus Pharmaceuticals Announces Third Quarter 2011 Financial Results 2Lotus Pharmaceuticals Announces Third Quarter 2011 Financial Results 3Lotus Pharmaceuticals Announces Third Quarter 2011 Financial Results 4Lotus Pharmaceuticals Announces Third Quarter 2011 Financial Results 5Lotus Pharmaceuticals Announces Third Quarter 2011 Financial Results 6
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications....
The VersaFluor cuvette fluorometer is a fast and simple way to quantitate DNA, RNA, and proteins, to detect apoptosis, and to perform reporter enzyme assays with the high level of sensitivity and sel...
... unique microprocessor-controlled filter wheels for wavelength selection ... filter wheels can be programmed for excitation ... With this fluorometer, you do not have ... wavelengths. The C&L Dye Fluorometer can measure ...
The TBS-380 Fluorometer is an economical, sensitive fluorometer designed for quick, easy, and accurate fluorescent measurements....
Medicine Products: